Vaccines for hantaviruses: Progress and issues

Expert Review of Vaccines

Volumn 11, Issue 5, 2012, Pages 511-513

  Schmaljohn, Connie S ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

hantavirus pulmonary syndrome; hantaviruses; hemorrhagic fever with renal syndrome; vaccines

Indexed keywords

DNA VACCINE; NEUTRALIZING ANTIBODY; RECOMBINANT VACCINE; VACCINIA VACCINE; VIRUS VACCINE;

ARMY; COST BENEFIT ANALYSIS; DOBRAVA VIRUS; EDITORIAL; ENDEMIC DISEASE; EPIDEMIC; FOOD AND DRUG ADMINISTRATION; HANTAVIRUS; HANTAVIRUS PULMONARY SYNDROME; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMAN; IMMUNOGENICITY; INCIDENCE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PUUMALA VIRUS; SEOUL VIRUS; SEROCONVERSION; SEROPREVALENCE; WAR;

HANTAVIRUS; HANTAVIRUS PULMONARY SYNDROME; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMANS; VIRAL VACCINES;

EID: 84862575161     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.12.15     Document Type: Editorial

References (19)

1. Nichol ST, Spiropoulou CF, Morzunov S et al. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 262(5135), 914-917 (1993
2. MacNeil A, Ksiazek TG, Rollin PE. Hantavirus pulmonary syndrome, United States, 1993-2009. Emerging Infect. Dis. 17(7), 1195-1201 (2011
3. Zhang YZ, Zou Y, Fu ZF, Plyusnin A. Hantavirus infections in humans and animals, China. Emerging Infect. Dis. 16(8), 1195-1203 (2010
4. Cho HW, Howard CR, Lee HW. Review of an inactivated vaccine against hantaviruses. Intervirology 45(4-6), 328-333 (2002
5. Heyman P, Ceianu CS, Christova I et al. A five-year perspective on the situation of haemorrhagic fever with renal syndrome and status of the hantavirus reservoirs in Europe, 2005-2010. Euro Surveill. 16(36), 1-8 (2011
6. Jonsson CB, Figueiredo LT, Vapalahti O. A global perspective on hantavirus ecology, epidemiology, and disease. Clin. Microbiol. Rev. 23(2), 412-441 (2010
7. Chu YK, Jennings GB, Schmaljohn CS. A vaccinia virus-vectored Hantaan virus vaccine protects hamsters from challenge with Hantaan and Seoul viruses but not Puumala virus. J. Virol. 69(10), 6417-6423 (1995
8. Hooper JW, Custer DM, Thompson E, Schmaljohn CS. DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys. J. Virol. 75(18), 8469-8477 (2001
9. Hukic M, Nikolic J, Valjevac A, Seremet M, Tesic G, Markotic A. A serosurvey reveals Bosnia and Herzegovina as a Europe's hotspot in hantavirus seroprevalence. Epidemiol. Infect. 138(8), 1185-1193 (2010
10. Balabanova Y, Gilsdorf A, Buda S et al. Communicable diseases prioritized for surveillance and epidemiological research: results of a standardized prioritization procedure in Germany, 2011. PLoS ONE 6(10), e25691 (2011
11. Macneil A, Nichol ST, Spiropoulou CF. Hantavirus pulmonary syndrome. Virus Res. 162(1-2), 138-147 (2011
12. Figueiredo LT, Moreli ML, de-Sousa RL et al.; Viral Diversity Genetic Network Consortium. Hantavirus pulmonary syndrome, central plateau, southeastern, and southern Brazil. Emerging Infect. Dis. 15(4), 561-567 (2009
13. Martinez VP, Bellomo CM, Cacace ML, Suarez P, Bogni L, Padula PJ. Hantavirus pulmonary syndrome in Argentina, 1995-2008. Emerging Infect. Dis. 16(12), 1853-1860 (2010
14. McClain DJ, Summers PL, Harrison SA, Schmaljohn AL, Schmaljohn CS. Clinical evaluation of a vaccinia-vectored Hantaan virus vaccine. J. Med. Virol. 60(1), 77-85 (2000
15. Boudreau EF, Josleyn M, Ullman D et al. A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for hemorrhagic fever with renal syndrome. Vaccine 30(11), 1951-1958 (2012
16. Vapalahti K, Paunio M, Brummer-Korvenkontio M, Vaheri A, Vapalahti O. Puumala virus infections in Finland: increased occupational risk for farmers. Am. J. Epidemiol. 149(12), 1142-1151 (1999
17. DiMasi JA, Hansen RW, Grabowski HG. The price of innovation: new estimates of drug development costs. J. Health Econ. 22(2), 151-185 (2003
18. Light DW, Warburton R. Demythologizing the high costs of pharmaceutical research. Biosocieties 6(1), 34-50 (2011
19. Hooper JW, Larsen T, Custer DM, Schmaljohn CS. A lethal disease model for hantavirus pulmonary syndrome. Virology 289(1), 6-14 (2001)